These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 27434855)

  • 21. Human papillomavirus vaccine update.
    Gilmer LS
    Prim Care; 2015 Mar; 42(1):17-32. PubMed ID: 25634702
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prophylactic quadrivalent vaccine for the prevention of infection and disease related to HPV-6, -11, -16 and -18.
    Goldstone SE; Vuocolo S
    Expert Rev Vaccines; 2012 Apr; 11(4):395-406. PubMed ID: 22551023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.
    Saraiya M; Unger ER; Thompson TD; Lynch CF; Hernandez BY; Lyu CW; Steinau M; Watson M; Wilkinson EJ; Hopenhayn C; Copeland G; Cozen W; Peters ES; Huang Y; Saber MS; Altekruse S; Goodman MT;
    J Natl Cancer Inst; 2015 Jun; 107(6):djv086. PubMed ID: 25925419
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inequalities in Human Papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination.
    Brisson M; Drolet M; Malagón T
    J Natl Cancer Inst; 2013 Feb; 105(3):158-61. PubMed ID: 23297040
    [No Abstract]   [Full Text] [Related]  

  • 25. HPV Vaccination in Latin America: Global Challenges and Feasible Solutions.
    Nogueira-Rodrigues A
    Am Soc Clin Oncol Educ Book; 2019 Jan; 39():e45-e52. PubMed ID: 31099692
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Re: Annual report to the nation on the status of cancer, 1975-2009, featuring the burden and trends in human papillomavirus (HPV)-associated cancers and HPV vaccination coverage levels and Re: Inequalities in human papillomavirus (HPV)-associated cancers: implications for the success of HPV vaccination.
    Harper DM; Groner JA; Griffith RS; Harper WH
    J Natl Cancer Inst; 2013 May; 105(10):749-50. PubMed ID: 23641042
    [No Abstract]   [Full Text] [Related]  

  • 27. If There Were A Vaccine Against Cancer..
    Pino R
    Conn Med; 2017 Jan; 81(1):45-46. PubMed ID: 29782767
    [No Abstract]   [Full Text] [Related]  

  • 28. Questions remain about the human papillomavirus vaccine.
    Printz C
    Cancer; 2009 Feb; 115(4):699-701. PubMed ID: 19189370
    [No Abstract]   [Full Text] [Related]  

  • 29. Considerations for human papillomavirus (HPV) vaccination of mid-adult women in the United States.
    Grant LA; Dunne EF; Chesson H; Markowitz LE
    Vaccine; 2011 Mar; 29(13):2365-70. PubMed ID: 21277406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prophylactic human papillomavirus vaccination: a breakthrough in primary cervical cancer prevention.
    Garcia FA; Saslow D
    Obstet Gynecol Clin North Am; 2007 Dec; 34(4):761-81, ix. PubMed ID: 18061868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Human papillomavirus and the HPV vaccine: are the benefits worth the risks?
    Knudtson M; Tiso S; Phillips S
    Nurs Clin North Am; 2009 Sep; 44(3):293-9. PubMed ID: 19683091
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The cost-effectiveness of male HPV vaccination in the United States.
    Chesson HW; Ekwueme DU; Saraiya M; Dunne EF; Markowitz LE
    Vaccine; 2011 Oct; 29(46):8443-50. PubMed ID: 21816193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus, current vaccines, and cervical cancer prevention.
    Teitelman AM; Stringer M; Averbuch T; Witkoski A
    J Obstet Gynecol Neonatal Nurs; 2009; 38(1):69-80. PubMed ID: 19208050
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP).
    Markowitz LE; Dunne EF; Saraiya M; Chesson HW; Curtis CR; Gee J; Bocchini JA; Unger ER;
    MMWR Recomm Rep; 2014 Aug; 63(RR-05):1-30. PubMed ID: 25167164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Swedish consensus on cervix cancer vaccination. Vaccination programs for eradication of HPV16/18 should be initiated in elementary schools].
    Dillner J; Andrae B; Westermark B
    Lakartidningen; 2006 Nov 1-7; 103(44):3377-9. PubMed ID: 17152260
    [No Abstract]   [Full Text] [Related]  

  • 36. The four steps in the prevention of human papillomavirus-associated neoplasia: considerations for preventive measures, screening, disease impact, and potential overtreatments in HPV-related pathology.
    Liverani CA
    Arch Gynecol Obstet; 2013 Nov; 288(5):979-88. PubMed ID: 23974280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The HPV vaccine controversy.
    Intlekofer KA; Cunningham MJ; Caplan AL
    Virtual Mentor; 2012 Jan; 14(1):39-49. PubMed ID: 23116916
    [No Abstract]   [Full Text] [Related]  

  • 38. HPV vaccine is now routinely indicated for males.
    Campos-Outcalt D
    J Fam Pract; 2012 Jan; 61(1):38-40. PubMed ID: 22220294
    [No Abstract]   [Full Text] [Related]  

  • 39. Economic evaluation of vaccination: capturing the full benefits, with an application to human papillomavirus.
    Bärnighausen T; Bloom DE; Cafiero ET; O'Brien JC
    Clin Microbiol Infect; 2012 Oct; 18 Suppl 5():70-6. PubMed ID: 22882176
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Philanthropic support of HPV vaccination efforts.
    McCandless B; Sharpe BR
    Prev Med; 2015 Jul; 76():126. PubMed ID: 25657169
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.